Residency Program

Solid Organ Transplant Pharmacy (PGY2)

Introduction

Duke was one of the first institutions in the country to successfully establish a kidney transplant program in 1965. Since then, Duke's transplantation programs have achieved many more national and regional milestones, including the state's first successful liver, heart, hand, and abdominal wall transplants. Annually the Duke Transplant Center performs over 500 solid organ transplants including heart, intestine, kidney, liver, lung, pancreas, and vascularized composite tissue transplants in pediatric and adult recipients. Clinical pharmacy services are provided to all of the organ groups via a multidisciplinary approach.

The solid organ transplant residency is a specialized program consisting of 12 months of training in various transplant settings. The program is designed to include several core experiences necessary for establishing a foundation of solid organ transplant knowledge. Due to the diverse experiences at Duke, the residency year is tailored to adapt to the needs and interests of the individual resident.

Purpose

Postgraduate Year Two (PGY2) pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and Postgraduate Year One (PGY1) pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.

The purpose of the PGY2 Solid Organ Transplant Residency Program is to prepare the resident to excel in the care of solid organ transplant recipients and donors in any setting as a clinical pharmacy specialist, clinical faculty member, or to continue post graduate training (e.g., another residency or fellowship). 

Excellence will be achieved by:

  • Demonstrating accountability for patient care
  • Modeling excellence in solid organ transplant pharmaceutical care
  • Serving as professional role models for pharmacy students and PGY1 residents
  • Participating in clinical research and performance improvement projects focused on solid organ transplant pharmacotherapy
  • Facilitating and leading solid organ transplant pharmacotherapy discussions in Solid Organ Transplant Pharmacy Conference 

Outcomes

Required Outcomes

  • In collaboration with the health care team, provide comprehensive medication management to solid organ transplant patients following a consistent patient care process.     
  • Ensure continuity of care during solid organ transplant patient transitions between care settings.
  • Manage and facilitate delivery of medications to support safe and effective drug therapy for solid organ transplant patients.
  • Demonstrate ability to manage formulary and medication-use processes for solid organ transplant patients, as applicable to the organization.
  • Demonstrate ability to conduct a quality improvement or research project.    
  • Demonstrate leadership skills for successful self-development in the provision of care for solid organ transplant patients.
  • Demonstrate management skills in the provision of care for solid organ transplant patients.                            
  • Provide effective medication and practice-related education to solid organ transplant patients, caregivers, health care professionals, students, and the public (individuals and groups).
  • Effectively employ appropriate preceptor roles when engaged in teaching students, pharmacy technicians, or fellow health care professionals in solid organ transplant.                  

PGY2 Solid Organ Transplant Residency Timeline

PGY2 Solid Organ Transplant Residency Brochure

Text:

-A A +A